D.Western Therapeutics Institute
4576.TTSE GROWTHPharmaceutical
Financials · Consolidated
| Fiscal year ended | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|---|
| Revenue | ¥388m | ¥472m | ¥428m | ¥448m | ¥414m | ¥356m |
| Operating income | −¥620m | −¥1.2bn | −¥799m | −¥306m | −¥172m | — |
| Ordinary income | −¥630m | −¥1.2bn | −¥796m | −¥296m | −¥160m | −¥290m |
| Net income (owners) | −¥632m | −¥1.3bn | −¥812m | −¥430m | −¥149m | −¥276m |
| Total assets | ¥2.2bn | ¥1.7bn | ¥2.4bn | ¥3.0bn | ¥2.5bn | ¥2.7bn |
| Net assets / equity | ¥1.4bn | ¥734m | ¥1.3bn | ¥1.9bn | ¥2.0bn | ¥2.2bn |
| Operating cash flow | −¥494m | −¥1.3bn | −¥587m | −¥355m | −¥176m | −¥216m |
| EPS (basic) | ¥-13.19 | ¥-36.74 | ¥-25.56 | ¥-14.5 | ¥-5.08 | ¥-10.16 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 3
| Period | Form | Figures |
|---|---|---|
| 2026-01-01 → 2026-06-30 | Half-year | 67 figures · EDINET |
| 2025-01-01 → 2025-06-30 | Half-year | 67 figures · EDINET |
| 2024-01-01 → 2024-06-30 | Half-year | 67 figures · EDINET |
22 more reports are still being processed.